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Source of material
The title compound was synthesized according to a reported procedure [5] . A mixture of 1,1-dimethyl-3,5-cyclohexanedione (10 mmol), 2,6-dichlorobenzaldehyde (10 mmol), malononitrile (10 mmol) and 4-(dimethylamino)pyridine (DMAP) (1 mmol) in ethanol (100 mL) was re uxed for 2-3 h and then 
cooled to room temperature. After ltering the precipitates, they were sequentially washed with ice-cooled water and ethanol and then dried under a vacuum.
Experimental details
All hydrogen atoms were placed geometrically on calculated positions using a riding model (AFIX options 13, 23, 33, 43 or 93 of the SHELX-2008 program [6] ).
Discussion
Dihydropyran and its derivatives have received considerable attention in the past few years for their versatile biological and medical activities because of di erent substituents on the aromatic ring leading to multiple chemical modi cations, such as antioxidant, anti-in ammatory, antibacterial and anticancer activities [1] [2] [3] . Recognizing the considerable importance of the compounds, research focused on the synthesis of dihydropyran derivatives [4] . There is one complete molecule in the asymmetric unit. All bond lengths and angles are in the expected ranges. In the crystal structure of the title compound, the new formed pyran ring is basically planar, whereas the cyclohexanonyl moiety is folded (see the gure).
